CXCR1 and neoplasm: Promoting neutrophil reverse migration to accelerate the resolution of inflammation by pharmacologically inhibiting Cxcr1-Cxcl8a signaling presents another approach to counteract inflammation and to restrict tumor progression (45, 97).